BioSpace News Archive

Business

HeartFlow Announces Collaborative Research Agreement with Imperial College London

Joint research in medical imaging and deep learning to help improve treatment planning for patients with heart disease

March 7, 2018
·
4 min read
Business

March of Dimes and Ferring Announce New Prematurity Research Center at Imperial College London

March 7, 2018
·
5 min read
Business

Danaher Provides Update On First Quarter 2018 Financial Performance

Danaher Corporation announced that it expects first quarter 2018 adjusted diluted net earnings per share to be above the high-end of the Company’s previously communicated guidance range.

March 7, 2018
·
1 min read
Biotech Bay

BIOLASE Secures $6 Million Revolving Line Of Credit

Will Help Fund Future Growth as Company Moves Toward Achieving Positive Operating Cash Flow and Profitability Goals

March 7, 2018
·
5 min read
FDA

Orthofix Secures FDA and CE Mark Approvals for New PhysioStim Bone Growth Stimulators

Devices unveiled today at AAOS Annual Meeting in New Orleans

March 7, 2018
·
4 min read
Drug Development

BioTime Announces DSMB Approval to Proceed to Cohort 4 of the OpRegen® Clinical Trial

Continued safety from cohorts 1, 2 and 3 included in assessment by independent DSMB; Cohort 4 will focus on earlier stage dry-AMD patients; Additional functional data assessments are included in Cohort 4

March 7, 2018
·
4 min read
Biotech Bay

Nektar to Webcast Presentation at the Cowen and Company 38th Annual Health Care Conference in Boston

Nektar Therapeutics’ (Nasdaq: NKTR) Senior Vice President and Chief Scientific Officer, Jonathan Zalevsky, Ph.D., is scheduled to present at the upcoming Cowen and Company 38th Annual Health Care Conference in Boston on Wednesday, March 14, 2018 at 8:00 a.m. Eastern Time.

March 7, 2018
·
1 min read
BioCapital

GlycoMimetics to Present at Four Investor Conferences This Month

GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that it will present at four investor conferences during the month of March

March 7, 2018
·
1 min read
Deals

Immuno-Oncology Sector Deals Dominate 2017 Life Sciences Deal of the Year Awards

Bristol-Myers Squibb acquisition of IFM Therapeutics, and Amgen-CytomX licensing deal recognized among more than 4,000 transactions in annual Cortellis Deal of the Year Awards from Clarivate Analytics

March 7, 2018
·
4 min read
Business

Trans-Hit Bio and Q&T Research enter into an Exclusive Strategic Business Partnership

Trans-Hit Bio (THB) is pleased to announce a strategic partnership with Q&T Research to facilitate access by the biopharma community to large quantities of blood collected by plasmapheresis from healthy donors and ambulatory patients that can be used to prepare the large volumes of PBMC.

March 7, 2018
·
1 min read